SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study.

Yanan HouJie ZhengTianzhichao HouHong LinTiange WangShuangyuan WangJieli LuZhiyun ZhaoMian LiYu XuYanqiu Wang Yu-Fang Bi Wei-Qing Wang

Published in: Diabetes care (2022)

Our study identified the causal roles of SGLT2 inhibition in choline metabolites. SGLT2 inhibition may influence T2D and CAD through different choline metabolites.

Keyphrases

ms ms
coronary artery disease
depressive symptoms
social support